ALM301
Product Specifications
CAS Number
1313439-71-2
Target
Others|||Akt
Related Pathways
Others|||PI3K/Akt/mTOR signaling|||Cytoskeletal Signaling
Bioactivity
ALM301 is a highly specific, orally active AKT inhibitor that acts on AKT1 (IC50: 0.13 ?M), AKT2 (IC50: 0.09 ?M) and AKT3 (IC50: 2.75 ?M) . ALM301 inhibits AKT phosphorylation in vitro and has a regulatory effect on downstream signalling. ALM301 exhibits inhibitory effects on cancer cell proliferation and tumor growth.
Smiles
CCN1C(=O)COc2nc(-c3ccc(cc3)[C@@]3(N)C[C@H](O)C3)c(cc12)-c1ccccc1
Molecular Formula
C25H25N3O3
Molecular Weight
415.48
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1431507-01 0.02 mg (E-Coli)
Recombinant Coxiella burnetii Bis (5'-nucleosyl) -tetraphosphatase, symmetrical (apaH)
Ask
View Details MBS1431507-02 0.1 mg (E-Coli)
Recombinant Coxiella burnetii Bis (5'-nucleosyl) -tetraphosphatase, symmetrical (apaH)
Ask
View Details 
MBS1431507-03 0.02 mg (Baculovirus)
Recombinant Coxiella burnetii Bis (5'-nucleosyl) -tetraphosphatase, symmetrical (apaH)
Ask
View Details 
MBS1431507-04 0.02 mg (Mammalian-Cell)
Recombinant Coxiella burnetii Bis (5'-nucleosyl) -tetraphosphatase, symmetrical (apaH)
Ask
View Details MBS1431507-05 0.1 mg (Baculovirus)
Recombinant Coxiella burnetii Bis (5'-nucleosyl) -tetraphosphatase, symmetrical (apaH)
Ask
View Details MBS1431507-06 1 mg (E-Coli)
Recombinant Coxiella burnetii Bis (5'-nucleosyl) -tetraphosphatase, symmetrical (apaH)
Ask
View Details